3 years ago

Response to: HCV Viremic Donors With Hepatic Bridging Fibrosis: Are We Ready To Use Their Livers in The Era of Direct-ActingAntivirals?

R. N. Formica, J. Levitsky
We read with interest the response by Martini et al to our consensus conference and recommendations on the use of hepatitis C viremic organs in negative recipients (1,2). Their case report is certainly provocative in considering fibrotic viremic donors, given the ability to eradicate HCV early and prevent further damage to a more injured graft. As we mentioned in our report, we should see an increase number of HCV-infected baby boomers within the next decade who have more likelihood of hepatic fibrosis compared to the younger, drug-injecting population (3). This article is protected by copyright. All rights reserved.

Publisher URL: http://onlinelibrary.wiley.com/resolve/doi

DOI: 10.1111/ajt.14478

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.